<!DOCTYPE html>
<!-- paulirish.com/2008/conditional-stylesheets-vs-css-hacks-answer-neither/
-->
<!--[if lt IE 7]>
<html class="no-js lt-ie9 lt-ie8 lt-ie7" lang="en">
<![endif]-->
<!--[if IE 7]>
<html class="no-js lt-ie9 lt-ie8" lang="en">
<![endif]-->
<!--[if IE 8]>
<html class="no-js lt-ie9" lang="en">
<![endif]-->
<!--[if gt IE 8]>
<!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<head>
    <meta charset="utf-8" />
    <!-- Set the viewport width to device width for mobile -->
    <meta name="viewport" content="width=device-width" />
    <title>
        PracticeUpdate : Expert Opinion Item
    </title>
    <link rel="stylesheet" href="assets/css/app.css">
    <link rel="stylesheet" href="assets/css/font-awesome.css">
    <link rel="stylesheet" href="assets/css/fc-webicons.css">
    <link rel="stylesheet" href="assets/css/foundation-icons-general.css">
    <script src="assets/js/foundation/modernizr.foundation.js">
    </script>
    <!-- IE Fix for HTML5 Tags -->
    <!--[if lt IE 9]>
        <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js">
        </script>
    <![endif]-->
</head>

<body id="page" class="update off-canvas slide-nav expert-opinion-item logged-out">
    <div class="widget ad">
        <div id="leaderboard" class="Breast ad-container">
            <div class="ad-title">
                <span class="ad-title-text">
                    advertisement
                </span>
            </div>
            <!--/.ad-title-->
            <div id="leaderboardcontent" class="ad-content">
            </div>
            <!--.ad-content-->
        </div>
        <!--/#leaderboard.ad-container-->
    </div>
    <!--/.widget.ad-->
    <div class="page-header">
    </div>
    <!--/.page-header-->
    <div class="page-content">
        <section role="main">
            <div class="single-item-container">
                <article class="type-expert-opinion single-item">
                    <!-- info taken from: http://oncologystat.com/viewpoints/seminal_articles/Seminal_Articles_Germ_Cell_Tumors.html
                    -->
                    <div class="item-header-container">
                        <header class="item-header">
                            <div class="flag-container">
                                <span class="flag featured">
                                    <i class="icon-bolt">
                                    </i>
                                    featured
                                </span>
                                <span class="flag story-of-the-week">
                                    <i class="icon-bolt">
                                    </i>
                                    story of the week
                                </span>
                            </div>
                            <div class="meta pub-meta">
                                <span class="item-type">
                                    Seminal Article
                                </span>
                                <span class="item-pub-date">
                                    <time datetime="12-12-19">
                                        December 19, 2012
                                </span>
                            </div>
                            <hgroup class="item-title-container">
                                <h1 class="item-title">
                                    Seminal Articles—Kidney Cancer
                                </h1>
                                <p class="item-citation">
                                    <!-- {{source.citation}} -->
                                    2012 Apr 11, Eric Jonasch, MD, Editor: Patrick Morris, MD
                                </p>
                            </hgroup>
                            <!-- /.item-title-container -->
                        </header>
                    </div>
                    <!--/.item-header-container-->
                    <div class="item-content-container">
                        <div class="item-content">
                            <div class="item-content-section">
                                <section class="seminal-article-body">
                                    <div class="seminal-article-body-container">
                                        <div class="source-container">
                                            <div class="vcard">
                                            </div>
                                            <!--/.vcard-->
                                        </div>
                                        <!--/.source-container-->
                                        <p>Based on our expert’s review, here are the must-read articles for every oncologist about kidney cancer.

</p><p><strong>Prognostic Algorithms</strong></p><p>1. Motzer RJ, Bacik J, Murphy BA, et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. <a target="_blank" href="http://jco.ascopubs.org/content/20/1/289.long">J Clin Oncol. 2002 Jan 1;20(1):289-296</a>.</p><p>2. DYC, Xie W, Regan MM, et al. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor&ndash;Targeted Agents: Results From a Large, Multicenter Study. <a target="_blank" href="http://jco.ascopubs.org/content/27/34/5794.full">J Clin Oncol. December 1, 2009;27(34):5794-5799</a>.</p><p><strong>Surgery</strong></p><p>3. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa003013">N Engl J Med. 2001 Dec 6;345(23):1655-1659</a>.</p><p>4. Mickisch GH, Garin A, van Poppel H, et al; European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0140673601061037">Lancet. 2001 Sep 22;358(9286):966-970</a>.</p><p>5. Leibovich BC, Blute ML, Cheville JC, et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0022534705624159">J Urol. 2004 Mar;171(3):1066-1070</a>. Elsevier</p><p>6. Blom JH, van Poppel H, Maréchal JM, et al; EORTC Genitourinary Tract Cancer Group. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0302283808011743">Eur Urol. 2009 Jan;55(1):28-34</a>. Elsevier</p><p>7. Chen DY, Uzzo RG. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759676/?tool=pubmed">J Natl Compr Canc Netw. 2009 Jun;7(6):635-642; quiz 643</a>. <strong>Free</strong></p><p>8. Culp SH, Tannir NM, Abel EJ, et al. Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy? <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/cncr.25046/full">Cancer. 2010 Jul 15;116(14):3378-3388</a>. <strong>Free</strong></p><p><strong>Adjuvant Cytokine Therapy</strong></p><p>9. Clark JI, Atkins MB, Urba WJ, et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. <a target="_blank" href="http://jco.ascopubs.org/content/21/16/3133.long">J Clin Oncol. 2003 Aug 15;21(16):3133-3140</a>.</p><p>10. Messing EM, Manola J, Wilding G, et al; Eastern Cooperative Oncology Group/Intergroup trial. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. <a target="_blank" href="http://jco.ascopubs.org/content/21/7/1214.long">J Clin Oncol. 2003 Apr 1;21(7):1214-1222</a>.</p><p><strong>Cytokines for Metastatic Disease</strong></p><p>11. Medical Research Council Renal Cancer Collaborators. Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0140673698035442">Lancet. Jan 2, 1999;353(9146):14-17</a>.</p><p>12. Pyrhonen S, Salminen E, Ruutu M, et al: Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. <a target="_blank" href="http://jco.ascopubs.org/content/17/9/2859.long">J Clin Oncol. Sept,1999;17(9):2859-2867</a>.</p><p>13. Negrier S, Perol D, Ravaud A, Escudier B, et al. Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis. <a target="_blank" href="http://onlinelibrary.wiley.com/doi/10.1002/cncr.23056/full">Cancer. Dec 1, 2007;110(11)2468-2477</a>. <strong>Free</strong></p><p>14. McDermott DF, Regan MM, Clark JI, et al. Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. <a target="_blank" href="http://jco.ascopubs.org/content/23/1/133.long">J Clin Oncol. 2005 Jan 1;23(1):133-141</a>.</p><p>15. Yang J, Sherry RM, Steinberg SM, et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. <a target="_blank" href="http://jco.ascopubs.org/content/21/16/3127.full">J Clin Oncol. Aug 15, 2003;21(16):3127-3132</a>.</p><p><strong>Tyrosine Kinase Inhibitors</strong></p><p>16. Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. <a target="_blank" href="http://www.nejm.org/doi/pdf/10.1056/NEJMoa065044">N Engl J Med. 2007 Jan 11;356(2):115-124</a>.</p><p>17. Escudier B, Eisen T, Stadler WM,et al; TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. <a target="_blank" href="http://www.nejm.org/doi/full/10.1056/NEJMoa060655">N Engl J Med. 2007 Jan 11;356(2):125-134</a>.</p><p>18. Escudier B, Szczylik C, Hutson TE, et al. Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma. <a target="_blank" href="http://jco.ascopubs.org/content/27/8/1280.full.pdf">J Clin Oncol. 2009 Mar 10;27(8):1280-1289</a>.</p><p>19. Sternberg CN, Davis ID, Mardiak J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. <a target="_blank" href="http://jco.ascopubs.org/content/28/6/1061.full.pdf">J Clin Oncol. 2010 Feb 20;28(6):1061-1068</a>.</p><p>20. Rini BI, Escudier B, Tomczak P, et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0140673611616139">Lancet. 2011 Dec 3;378(9807):1931-1939</a>. Elsevier</p><p><strong>Bevacizumab</strong></p><p>21. Escudier B, Pluzanska A, Koralewski P, et al; AVOREN Trial investigators. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0140673607619047">Lancet. 2007 Dec 22;370(9605):2103-2111</a>. Elsevier</p><p>22. Rini BI, Halabi S, Rosenberg JE, et al. Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651074/?tool=pubmed">J Clin Oncol. 2010 May 1;28(13):2137-2143</a>. <strong>Free</strong></p><p><strong>mTOR Inhbitors</strong></p><p>23. Hudes G, Carducci M, Tomczak P, et al; Global ARCC Trial. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. <a target="_blank" href="http://www.nejm.org/doi/pdf/10.1056/NEJMoa066838">N Engl J Med. 2007 May 31;356(22):2271-2281</a>.</p><p>24. Motzer RJ, Escudier B, Oudard S, et al; RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. <a target="_blank" href="http://www.sciencedirect.com/science/article/pii/S0140673608610399">Lancet. 2008 Aug 9;372(9637):449-456</a>. Elsevier</p><p></p>
                                    </div>
                                    <!--/.seminal-article-body-container -->
                                </section>
                                <!-- /.seminal-article-body -->
                            </div>
                            <!-- ./item-content-section -->
                        </div>
                        <!-- ./item-content -->
                    </div>
                    <!-- /.item-conten-container -->
                    <hr />
                    <footer class="copyright item-footer">
                        <img class="logo" src="content/img/feed/imng_logo.gif" alt="IMNG Medical Media"
                        />
                        <p>
                            Copyright &copy; 2012 Elsevier
                        </p>
                    </footer>
            </div>
            <!--/.item-container-->
            <div class="recommended">
                <div class="recent">
                </div>
                <!--/.recent-->
                <div class="ad">
                    <img src="http://placehold.it/300x250" align="ad" title="ad" />
                </div>
            </div>
            <!--/.recommended-->
        </section>
        <!--/[role="main"]-->
        <section id="sidebar" role="complementary">
            <div class="dashboard">
                <div class="panel cta register">
                    <p>
                        <!-- Meet Our Experts -->
                        Become a member to customize this page.
                        <p>
                            <a class="button" href="#action-register">Register for free</a>
                </div>
                <!--/.panel.cta.register-->
                <div class="component user-console">
                </div>
                <!--/.component.user-console-->
                <div class="component user-topic">
                </div>
                <!--/.component.user-topic-->
                <div class="component topic-spotlight">
                </div>
                <!--/.component.topic-spotlight-->
                <div class="panel">
                    <img src="http://placehold.it/200x200" />
                    <p>
                        <!-- Meet Our Experts -->
                        Meet our Advisory and Editorial Boards comprised of physician editors
                        and world-renowned experts.
                        <p>
                </div>
            </div>
            <!--/.sidebar-->
        </section>
        <!--/.[role="complimentary"]-->
    </div>
    <!--/.page-content-->
	<div class="page-footer-container">
    <footer class="page-footer">
    </footer>
	</div><!-- /.page-footer-container -->
    <!-- /.page-footer -->
    <!-- Included JS Files (Uncompressed) -->
    <script src="assets/js/foundation/jquery.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.accordion.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.alerts.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.buttons.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.forms.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.mediaQueryToggle.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.navigation.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.orbit.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.reveal.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tabs.js">
    </script>
    <script src="assets/js/foundation/jquery.foundation.tooltips.js">
    </script>
    <script src="assets/js/foundation/jquery.placeholder.js">
    </script>
    <script src="assets/js/foundation/app.js">
    </script>
    <script src="assets/js/foundation/jquery.offcanvas.js">
    </script>
    <script src="assets/js/mustache.js">
    </script>
    <!-- Mustache - homepage feed template -->
    <script>
                    	<!--
	Mustache - homepage feed template -->
	$.getJSON('content/json/feed.json', function(data) {
	    $.get('assets/mustache/feed-item.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.stream-container').html(html);
	    });

	});

	<!--
	Mustache - homepage recent template -->
	$.getJSON('content/json/recent.json', function(data) {
	    $.get('assets/mustache/recent.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.recent').html(html);
	    });

	});

	<!--
	Mustache - homepage user - console template -->
	$.getJSON('content/json/user-console.json', function(data) {
	    $.get('assets/mustache/user-console.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-console').html(html);
	    });
	});

	<!--
	Mustache - homepage user - topic template -->
	$.getJSON('content/json/user-topic.json', function(data) {
	    $.get('assets/mustache/user-topic.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.user-topic').html(html);
	    });
	});

	<!--
	Mustache - homepage topic - spotlight template -->
	$.getJSON('content/json/topic-spotlight.json', function(data) {
	    $.get('assets/mustache/topic-spotlight.mustache', function(template) {
	        //alert('Load was performed.');
	        var html = Mustache.to_html(template, data);
	        $('.topic-spotlight').html(html);
	    });
	});
</script>
</body>

</html>